PATEL SUJAL M (CEO, President, and Secretary) purchased 0.4% of their position (35.53K shares) of NAUTILUS BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $99.1K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/7/2024ACC: 0001628280-24-009754
DirectorOfficer10% Owner· CEO, President, and Secretary
Since Jun 2021
+35.53K
Net shares
Net buyer
$99.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
35.53K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.41K
Price / share
$2.65
Trade value
$19.60K
% of position
0.1%
3/5/2024
10.01M→10.02M
Common Stock
Direct
Shares
+9.27K
Price / share
$2.70
Trade value
$25.03K
% of position
0.1%
3/6/2024
10.02M→10.03M
Common Stock
Direct
Shares
+18.85K
Price / share
$2.89
Trade value
$54.42K
% of position
0.2%
3/7/2024
10.03M→10.05M
Total
Net shares
+35.53K
Net value
$99.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2024 | P · Purchase | +7.41K | $2.65 | $19.60K | 0.1% | 10.01M | 10.02M |
| Common Stock Direct | 3/6/2024 | P · Purchase | +9.27K | $2.70 | $25.03K | 0.1% | 10.02M | 10.03M |
| Common Stock Direct | 3/7/2024 | P · Purchase | +18.85K | $2.89 | $54.42K | 0.2% | 10.03M | 10.05M |
| Total | +35.53K | $99.05K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned5.28M
Common Stock
IndirectShares owned1.81M
Total
7.09M indirect7.09M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.28M | Indirect |
| Common Stock | 1.81M | Indirect |
| Total | 7.09M | 7.09M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported